Skip to main content

Advertisement

Log in

Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin®) for treatment of angoid streaks in pseudoxanthoma elasticum

  • Case Report
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

To report a case of nonarteritic anterior ischemic optic neuropathy (NA-AION) following intravitreal injection of bevacizumab (Avastin®).

Methods

Interventional case report with an 18-month follow-up.

Results

A 51-year-old male with pseudoxanthoma elasticum presented with NA-AION 2 weeks after treatment with intravitreal of bevazicumab (Avastin®) for choroidal neovascularisation secondary to angioid streaks. Except from a small optic disc without cupping he did not show further risk factors.

Discussion

Risk of NA-AION should be taken into consideration when deciding for intravitreal application of drugs including anti-vascular endothelial growth factors (VEGF) agents like bevacizumab (Avastin®) in the treatment of retinal vascular diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Bhatnagar P, Freund KB, Spaide RF, Klancnik JM Jr, Cooney MJ, Ho I, Fine HF, Yannuzzi LA (2007) Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum. Retina 27:897–902

    Article  PubMed  Google Scholar 

  2. Rinaldi M, Dell'Omo R, Romano MR, Chiosi F, Cipollone U, Costagliola C (2007) Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks. Arch Ophthalmol 125:1422–1423

    Article  PubMed  Google Scholar 

  3. Teixeira A, Moraes N, Farah ME, Bonomo PP (2006) Choroidal neovascularization treated with intravitreal injection of bevacizumab (Avastin) in angioid streaks. Acta Ophthalmol Scand 84:835–836

    Article  PubMed  Google Scholar 

  4. Sachdev N, Vishwanathan K, Gupta V, Singh R, Gupta A (2007) Intravitreal bevacizumab (Avastin) in choroidal neovascular membrane in angioid streaks. Indian J Ophthalmol 55:457–458

    Article  PubMed  Google Scholar 

  5. Lommatzsch A, Spital G, Trieschmann M, Pauleikhoff D (2007) Intraocular application of bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks. Ophthalmologe 104:325–328

    Article  CAS  PubMed  Google Scholar 

  6. Wu L, Martinez-Castellanos MA, Quiroz-Mercado H et al (2008) Twelve-month safety of intravitreal injections of bevacizumab (Avastin®): Results of the Pan-American Collaborative Retina Study Group (PACORES). Graefes Arch Clin Exp Ophthalmol 246:81–87

    Article  CAS  PubMed  Google Scholar 

  7. Hayreh SS, Zimmerman MB (2007) Incipient nonarteritic anterior ischemic optic neuropathy. Ophthalmology 114:1763–1772

    Article  PubMed  Google Scholar 

  8. Ziemssen F, Bartz-Schmidt KU, Grisanti S (2006) (Neben)-Wirkungen der VEGF-inhibition. Ophthalmologe 130:484–490

    Article  Google Scholar 

  9. Newman NJ (2007) The ischemic optic neuropathy decompression trail. Arch Ophthalmol 125:1568–1570

    Article  PubMed  Google Scholar 

  10. Wilhelm B, Lüdtke H, Wilhelm H (2006) BRAION Study Group: Efficacy and tolerability of 0.2% brimonidine tartrate for the treatment of acute non-arteritic anterior ischemic optic neuropathy (N-AION): A 3-month, double-masked, randomised, placebo-controlled trial. Graefes Arch Clin Exp Ophthalmol 244:551–558

    Article  CAS  PubMed  Google Scholar 

  11. Hayreh SS (2009) Ischemic optic neuropathy. Prog Retin Eye Res 28:34–62

    Article  PubMed  Google Scholar 

  12. Hayreh SS, Zimmerman MB (2008) Non-arteritic anterior ischemic: role of systemic corticosteroid therapy. Graefes Arch Clin Exp Ophthalmol 246:1029–1046

    Article  CAS  PubMed  Google Scholar 

  13. Bennett JL, Thomas S, Olson JL, Mandava N (2007) Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab. J Neuroophthalmol 27:238–240

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sabine Aisenbrey.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ganssauge, M., Wilhelm, H., Bartz-Schmidt, KU. et al. Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin®) for treatment of angoid streaks in pseudoxanthoma elasticum. Graefes Arch Clin Exp Ophthalmol 247, 1707–1710 (2009). https://doi.org/10.1007/s00417-009-1184-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-009-1184-5

Keywords

Navigation